Product NDC: | 61703-359 |
Proprietary Name: | Epirubicin Hydrochloride |
Non Proprietary Name: | EPIRUBICIN HYDROCHLORIDE |
Active Ingredient(s): | 2 mg/mL & nbsp; EPIRUBICIN HYDROCHLORIDE |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 61703-359 |
Labeler Name: | Hospira Worldwide, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA065343 |
Marketing Category: | ANDA |
Start Marketing Date: | 20070808 |
Package NDC: | 61703-359-02 |
Package Description: | 1 VIAL, SINGLE-USE in 1 CARTON (61703-359-02) > 100 mL in 1 VIAL, SINGLE-USE |
NDC Code | 61703-359-02 |
Proprietary Name | Epirubicin Hydrochloride |
Package Description | 1 VIAL, SINGLE-USE in 1 CARTON (61703-359-02) > 100 mL in 1 VIAL, SINGLE-USE |
Product NDC | 61703-359 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | EPIRUBICIN HYDROCHLORIDE |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20070808 |
Marketing Category Name | ANDA |
Labeler Name | Hospira Worldwide, Inc. |
Substance Name | EPIRUBICIN HYDROCHLORIDE |
Strength Number | 2 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Anthracycline Topoisomerase Inhibitor [EPC],Anthracyclines [Chemical/Ingredient],Topoisomerase Inhibitors [MoA] |